Basel, Switzerland, 2007/07/10
On July 10th, 2007, Swiss-based computational biology provider Genedata AG announced its collaboration with FRISYS, the Freiburg Initiative for Systems Biology recently founded under the umbrella of the Centre for Systems Biology (ZBSA) in Freiburg, Germany. FRISYS focuses on modelling and systems analysis of signalling processes in growth and differentiation: in human cells; in model photosynthetic organisms such as cyanobacteria, the moss Physcomitrella patens and the plant Arabidopsis thaliana; and in the animal models zebrafish and Caenorhabditis elegans, a roundworm. FRISYS is one of four FORSYS (Forschungseinheiten der Systembiologie) Systems Biology Centers funded by the German Federal Ministry of Education and Research (BMBF).
Both the experimental and theoretical FRISYS research groups can rely on a tailor-made central data management and analysis platform provided by Genedata. Based on Genedata`s proven Phylosopher and Expressionist solutions, the customized system specifically addresses pathway modelling applications and is capable of analyzing large volumes of data, to investigate signalling and regulatory pathway wiring schemes in the various model organisms.
“Scientists from developmental biology and plant sciences as well as from the medical field are joining forces for our systems biology projects. Therefore, establishing a data management and analysis solution that can accommodate a wide range of needs was a prerequisite for FRISYS. Genedata provides us with a scalable, flexible and central platform that allows our scientists to store and exchange data sets and research results. In addition, they can effectively communicate findings from emerging fields such as transcriptional cascades, phospho-proteomics and small non-coding RNAs and simulation,” explains FRISYS spokesman Prof. Dr. Wolfgang R. Hess.
"Our collaboration with FRISYS is yet another step in further expanding Genedata’s position in the Systems Biology domain. Systems Biology has matured over the last few years and is increasingly being adopted by industries such as pharma, agro, biotechnology, and nutrition,” says Dr. Othmar Pfannes, CEO of Genedata AG. “We are delighted to support such an outstanding initiative as FRISYS with our computational solutions.”
Contact:
Genedata AG
Thomas Hartsch
Phone +41 61 697 8292
Fax +41 61 697 7244
thomas.hartsch@genedata.com
www.genedata.com
FRISYS
Sabine Stebel
Phone +49 761 203 2789
Fax +49 761 203 6996
sabine.stebel@biologie.uni-freiburg.de
www.frisys.biologie.uni-freiburg.de
Genedata specializes in discovery informatics for biotech, pharmaceuticals and the life sciences. The Company offers expertise in research informatics combined with open and scalable computational solutions. Our solutions include Genedata Phylosopher® for integrating, structuring, and analyzing research data. Genedata Screener® for high throughput screening analysis. And Genedata Expressionist® for omics data integration, processing and analysis. Founded in 1997 as a privately held spin off from Novartis, Genedata is headquartered in Basel, Switzerland and has branches in Tokyo (Japan), Munich (Germany), Boston (USA) and San Francisco (USA). The Company is also represented in Taiwan and Singapore. For more information about Genedata, please visit: www.genedata.com.
FRISYS (Freiburg Initiative for Systems Biology) is one of four FORSYS systems biology centers funded by the German Federal Ministry of Education and Research (BMBF). The Freiburg systems biology initiative (FRISYS) was founded under the umbrella of the Freiburg Centre for Systems Biology (ZBSA, Zentrum für Biosystemanalyse). Based on an interdisciplinary Systems Biology approach, FRISYS focuses on modelling and systems analysis of signalling processes in growth and differentiation of model organisms at phylogenetic key positions. Cooperations with the other FORSYS centers and leading Systems Biology institutions and initiatives worldwide are being established. For more information on FRISYS, please visit: www.frisys.biologie.uni-freiburg.de.
Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Related Files:
Download PDF